Austrianova is one company that does businesses that comprises high tech, life sciences and biotech.

It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based business that associates in the indusion of living cells or bacteria in tiny pills for shield which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was based in Singapore's greatest study biotech hub, Biopolis that has large-scale goal in offering encapsulation facilities like micro encapsulation.

There is a quick growing area of liking in healthy care and more precise, in the topic of neutraceuticals which is the understanding and use of probiotic bacteria. So, probiotics encapsulation was created. The cell-in-a-box technology was developed by Austranova with the goal to guard, separate, collect and move living cells. This proprietary finding can be used for several purposes and can be applied to probiotics, cosmetics and agriculture environmental protection and watching as well as creating the basis of a authoritative exploration device.

In healthcare, this skill supports run harmless attaching of cells or stem cells such as cell therapy, sticking them alone from the immune system and giving long term manufacturing of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure guards cells in bioreactors and fermentors and at the same time, it make simpler sanitization of bioproducts produced from the cells and it cut down constructing rate too.

A huge gauge cGMP facility for the making of biomedical grade encapsulated cell things was previously positively established and right now, Austrianova is in the journey of building this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a victory for pancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit minor quantities of chemotherapy to be used more effectually without the normal incapacitating side consequences. The encapsulated cell are positioned, using supraselective catheterisation, into blood vessels that leads to the tumor where they locally alter a chemotherapeutic product to its tumor toxic product.

Come to our website for additional details: Encapsulation Services, Cell Therapy , Stem Cells.